Indicateurs
1 Consultations de la notice
- Titre
- Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial
- Créateurs - sans rôle
- Mario Castro - University of KansasAlberto Papi - University of FerraraCeleste Porsbjerg - Bispebjerg and Frederiksberg Hospital, Copenhagen, DenmarkNjira Lugogo - University of Michigan, Ann Arbor, MI, USAChristopher Brightling - Institute for Lung Health, NIHR Leicester Biomedical Research Center, University of Leicester, UKFrancisco-Javier González-Barcala - University Hospital of Santiago de Compostela, Santiago de Compostela, SpainArnaud Bourdin - InsermMykola Ostrovskyy - Ivano-Frankivsk National Medical University, Ivano-Frankivsk, UkraineMaria Staevska - Medical University of SofiaPai-Chen Chou - Taipei Medical University Hospital, Taipei City, TaiwanLiliana Duca - Clinica Neomed, Brasov, RomaniaAna Pereria - Instituto and Hospital CUF Porto, Porto, PortugalCharles Fogarty - Spartanburg Medical Research, Spartanburg, SC, USARufai Nadama - King Khalid University HospitalMei Zhang - Sanofi, Bridgewater, NJ, USAAmelie Rodrigues - Ividata, Levallois-Perret, FranceXavier Soler - RegeneronSimona Pantelimon - Sanofi, Bucharest, RomaniaHarry Sacks - Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAYamo Deniz - RegeneronPaul Rowe - Sanofi, Bridgewater, NJ, USALucia De Prado Gomez - Sanodi, Madrid, SpainJuby Jacob-Nara - Sanofi, Bridgewater, NJ, USA
- Détails de publication
- Journal of allergy and clinical immunology, Vol.153(2), pp.AB368-AB368
- Éditeur
- Elsevier Inc
- Identifiants
- 99158901009311
- Unité académique
- Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
- Langue
- English
- Type de ressource
- Journal article